Gregory Russotti - 09 Jun 2025 Form 4 Insider Report for Century Therapeutics, Inc. (IPSC)

Role
Title: Chief Technology and Manufacturing Officer
Signature
/s/ Douglas Carr, Attorney-in-Fact
Issuer symbol
IPSC
Transactions as of
09 Jun 2025
Net transactions value
-$327
Form type
4
Filing time
11 Jun 2025, 17:04:34 UTC
Previous filing
12 Mar 2025
Next filing
10 Sep 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Russotti Gregory Title: Chief Technology and Manufacturing Officer C/O CENTURY THERAPEUTICS, INC., 25 N 38TH STREET, 11TH FLOOR, PHILADELPHIA /s/ Douglas Carr, Attorney-in-Fact 11 Jun 2025 0001867305

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction IPSC Common Stock Sale $327 -526 -0.13% $0.6220 392,047 09 Jun 2025 Direct F1
holding IPSC Common Stock 92,773 09 Jun 2025 By Gregory Russotti 2021 Family Trust
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sales reported on this Form 4 represent the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person.

Remarks:

Title: Chief Technology and Manufacturing Officer